
Hims & Hers shares rise as company adds new weight-loss medications to platform
The Hims app arranged on a smartphone in New York on Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health shares closed up 5% on Tuesday after the company announced patients can access Eli Lilly‘s weight loss medication Zepbound and diabetes drug Mounjaro, as well as the generic injection liraglutide,…